Use of Nebulized Hypertonic Saline in Patients With Neuromuscular Diseases or Cerebral Palsy in the United Kingdom使用雾化高渗盐水治疗英国神经肌肉疾病或脑瘫患者PEDIATRIC PULMONOLOGYIF2.32024-12-310PRE
Antibiotics for chronic pulmonary infection in children with a neurodisability (neurodevelopmental disorder)COCHRANE DATABASE OF SYSTEMATIC REVIEWSIF9.42023-02-091OAAI
Is aspergillus isolation (without ABPA) associated with a decline in FEV1 in CF?EUROPEAN RESPIRATORY JOURNALIF212019-11-210PRE
Caucasian small for gestational age infants with bronchopulmonary dysplasia require longer, and more intensive treatment for their disease than appropriate for gestational age, and non-Caucasian counterparts.EUROPEAN RESPIRATORY JOURNALIF212018-11-190PRE
Early experience of oxygen enhanced magnetic resonance imaging (OE-MRI) in ataxia telangiectasia (A-T)EUROPEAN RESPIRATORY JOURNALIF212018-11-190PRE
Early Respiratory Bacterial Detection and Antistaphylococcal Antibiotic Prophylaxis in Young Children with Cystic FibrosisANNALS OF THE AMERICAN THORACIC SOCIETYIF5.42018-01-0124OAAI
Maternal smoking in pregnancy increases the duration of home oxygen therapy in infants with bronchopulmonary dysplasiaEUROPEAN RESPIRATORY JOURNALIF212017-12-061PRE
The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providersTHORAXIF7.72017-08-04177OAAI
Weight-based oxygen flow rate is predictive of successful weaning of long-term oxygen therapy in babies with bronchopulmonary dysplasiaEUROPEAN RESPIRATORY JOURNALIF212016-11-081PRE
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosisCOCHRANE DATABASE OF SYSTEMATIC REVIEWSIF9.42015-07-3017OAAI
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosisCOCHRANE DATABASE OF SYSTEMATIC REVIEWSIF9.42015-02-2410OAAI
Rate of improvement of CF life expectancy exceeds that of general population-Observational death registration studyJOURNAL OF CYSTIC FIBROSISIF62014-07-0163OAAI
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosisCOCHRANE DATABASE OF SYSTEMATIC REVIEWSIF9.42013-06-056OAAI
Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosisCOCHRANE DATABASE OF SYSTEMATIC REVIEWSIF9.42013-02-2814PREAI
New agents to treat lung infection in cystic fibrosis: a big enough leap?FUTURE MEDICINAL CHEMISTRYIF3.42013-01-302PREAI
Fluoroquinolones in the treatment of bronchopulmonary disease in cystic fibrosistherapeutic advances in musculoskeletal diseaseIF32012-09-117OAAI
Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosisJOURNAL OF CYSTIC FIBROSISIF62012-07-01113OAAI
Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosisEUROPEAN RESPIRATORY JOURNALIF212012-06-27103OAAI
Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional studyBMJ-BRITISH MEDICAL JOURNALIF42.72012-01-03211OAAI